Document is current
Any future updates will be listed below
-
Authors
Vidor, Marcos Vinícius
Vitola, Eduardo Schneider
Bandeira, Cibele Edom
Martins, Alexandre Ribeiro
de Araujo Tavares, Maria Eduarda
Cupertino, Renata Basso
Panzenhagen, Alana Castro
da Silva, Bruna Santos
Falkenberg, Isabel Ghirardi
Barreto, Pedro Olavo
Teche, Stefania Pigatto
Picon, Felipe Almeida
Rohde, Luis Augusto
Rovaris, Diego L.
Bau, Claiton Henrique Dotto
Grevet, Eugenio Horacio
- License Information
-
More Information
Article History
Received: 10 May 2023
Accepted: 2 April 2024
First Online: 16 May 2024
Declarations
:
: Dr. Vidor was the recipient of a PhD scholarship from Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES—PBE-DPM, Bolsa Especial para Doutorado em Pesquisa Médica). Luis Augusto Rohde has received honoraria, has been on the speakers’ bureau/advisory board, and/or has acted as a consultant for Medice, Novartis/Sandoz, and Shire/Takeda in the last two years, and receives authorship royalties from OxfordPress and ArtMed. The ADHD and Juvenile Bipolar Disorder Outpatient Programs chaired by him has received unrestricted educational and research support from the following pharmaceutical companies in the last three years: Janssen-Cilag, Novartis/Sandoz, and Shire/Takeda. Eugênio Horácio Grevet has served as a speakers’ bureau/advisory board for Shire Pharmaceuticals in the past 3 years and has received travel awards from Shire for taking part in psychiatric meetings. Dr. Vitola, MSc Bandeira, Mr. Martins, MSc Tavares, Dr. Cupertino, Ms. Panzehagen, Dr. da Silva, Ms. Falkenberg, Mr. Barreto, Dr. Teche, Dr. Picon, Dr. Rovaris, and Dr. Bau reported no biomedical financial interests or potential conflicts of interest.
